51 Biggest Movers From Thursday

Gainers

• MedAvail Holdings, Inc. MDVL shares surged 69.4% to close at $2.44 on Thursday. Ally Bridge Group recently reported a purchase of 21.176 million shares of MedAvail Holdings for an average price of $1.06 per share.
• Indonesia Energy Corporation Limited INDO gained 65.9% to close at $26.40 on continued volatility. The small-cap energy stock has surged amid strength in oil prices in recent months.
• Houston American Energy Corp. HUSA climbed 38.5% to close at $4.86.
• Cumulus Media Inc. CMLS shares climbed 39.9% to close at $14.21 amid report a consoritum led by Jeff Warshaw has offered to buy the company between $15-$17/share.
• AppTech Payments Corp. APCX climbed 36.4% to close at $2.25.
• Marine Petroleum Trust MARPS gained 27.5% to settle at $9.61 on continued volatility. The nano-cap energy stock has surged amid strength in oil prices in recent months, but it has been trending lower in recent weeks.
• SCWorx Corp. WORX gained 25.8% to close at $1.12 as the company reached an agreement in principle with SEC staff to resolve previously disclosed SEC matter.
• Clarus Therapeutics Holdings, Inc. CRXT climbed 25.3% to close at $1.24 on above-average volume.
• Mexco Energy Corporation MXC rose 20.8% to close at $19.34.
• Lyra Therapeutics, Inc. LYRA gained 20.4% to close at $7.51.
• NextDecade Corporation NEXT jumped 19.5% to close at $7.37.
• Trevi Therapeutics, Inc. TRVI climbed 18% to close at $3.28. Trevi Therapeutics 10%+ shareholder Scott Sandell reported the purchase of 6,580,526 shares at an average price of $1.90/share in Form 4 filing.
• Airgain, Inc. AIRG gained 18.9% to close at $8.32 after the company was selected by a US-based water utility company to improve the connectivity of its fleet. No terms were disclosed.
• Cardiol Therapeutics Inc. CRDL jumped 17.8% to close at $2.05.
• Lexaria Bioscience Corp. LEXX rose 17.1% to close at $3.83 after the company reported safety and efficacy findings from its simulated pulmonary hypertension clinical study HYPER-H21-3.
• Renren Inc. RENN shares climbed 16.7% to close at $26.78. Renren recently signed a Software License and Distribution Agreement with Guangzhou Yupu Software Technology Co Ltd.
• Tantech Holdings Ltd TANH gained 16.3% to settle at $0.50.
• Verastem, Inc. VSTM gained 15.7% to close at $1.77 after RBC Capital initiated coverage on the stock with an Outperform rating and a $5 price target.
• Inozyme Pharma, Inc. INZY gained 15.5% to close at $4.26. The company announced an underwritten offering of 16,276,987 shares of its common stock at $3.69 per share for gross proceeds of ~$73 million.
• Borqs Technologies, Inc. BRQS jumped 15.3% to close at $0.1963 after the company signed a set of revised licensing agreements with Qualcomm, including a 5G licensing agreement to design and manufacture 5G products based on the Qualcomm latest technologies.
• Amesite Inc. AMST jumped 15.3% to close at $0.6699.
• CoreCivic, Inc. CXW rose 15% to close at $13.45 after Wedbush upgraded the stock from Neutral to Outperform and announced a $17 price target.
• RISE Education Cayman Ltd REDU rose 14.6% to close at $1.26.
• Cellectar Biosciences, Inc. CLRB jumped 14.3% to close at $0.6886. Cellectar Biosciences, last month, reported better-than-expected Q4 EPS results.
• Imperial Petroleum Inc. IMPP climbed 14.1% to close at $1.46.
• Siyata Mobile Inc. SYTA gained 12.7% to settle at $1.24.

Don’t forget to check out our premarket coverage here .

Losers

• Genius Group Limited GNS shares dipped 59.1% to close at $7.95 on continued volatility following the stock's recent IPO.
• Histogen Inc. HSTO shares fell 36.4% to close at $0.2468 on above-average volume.
• Singularity Future Technology Ltd. SGLY fell 23.2% to close at $6.46.
• Protagonist Therapeutics, Inc. PTGX fell 21.8% to close at $19.95 after the company received a letter from the FDA indicating the agency's intent to rescind Breakthrough Therapy Designation for the company's rusfertide product candidate in polycythemia vera.
• Guardforce AI Co., Limited GFAI fell 20.2% to close at $0.9017. Guardforce AI regained compliance with Nasdaq listing requirements.
• Lixte Biotechnology Holdings, Inc. LIXT dipped 19.9% to close at $1.57. LIXTE Biotechnology recently announced a $5.8 million registered direct offering priced at-the-market.
• Pyxis Oncology, Inc. PYXS fell 19.4% to close at $3.65.
• Forge Global Holdings, Inc. FRGE fell 19.3% to close at $13.56.
• Evolving Systems, Inc. EVOL dropped 18.5% to settle at $1.45 after the company announced it has notified Nasdaq of its intention to voluntarily withdraw its common stock.
• Rail Vision Ltd. RVSN fell 17.9% to close at $1.65 following recent IPO.
• Shineco, Inc. SISI dropped 17.7% to close at $1.81. Shineco announced entering into a securities purchase agreement with gross proceeds of $2.2 million.
• ION Geophysical Corporation IO dropped 17.5% to close at $0.3492 after the company filed for voluntary Chapter 11 relief in the U.S. Bankruptcy Court.
• ATRenew Inc. RERE declined 17.4% to close at $2.62.
• Ayala Pharmaceuticals, Inc. AYLA dropped 17% to close at $3.07.
• Cambium Networks Corporation CMBM dipped 16.6% to close at $16.95 after the company cut its Q1 sales guidance below analyst estimates.
• Zymergen Inc. ZY shares fell 16.6% to close at $1.76.
• PhaseBio Pharmaceuticals, Inc. PHAS fell 16.5% to close at $1.27 a.
• Burning Rock Biotech Limited BNR dipped 16% to close at $7.23.
• American Rebel Holdings, Inc. AREB dropped 16% to close at $1.47.
• IsoPlexis Corporation ISO dipped 15.4% to close at $2.30.
• Sunshine Biopharma, Inc. SBFM fell 15.3% to close at $4.03.
• Biofrontera Inc. BFRI fell 15.3% to close at $4.20. Biofrontera recently announced the FDA approval of its cGMP laboratory in Germany for batch control and stability testing of Ameluz.
• Artelo Biosciences, Inc. ARTL shares fell 15% to close at $0.43. Artelo Biosciences recently reported pre-clinical results for its G-Protein Coupled Receptor for the treatment of cancer-related anorexia.
• Cerberus Cyber Sentinel Corporation CISO fell 14.7% to close at $4.51.
• Esports Entertainment Group, Inc. GMBL shares fell 14.2% to close at $0.6292. Pulse Biosciences recently reported worse-than-expected Q4 EPS and sales results.